Position in EXEL
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$11,850,335
+$543,291 QoQ
Shares Held
276,296
+7.1% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Treasurer of the State of North Carolina holds $227,922,242 across 22 Biotechnology names. EXEL ranks #7 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
108,663 | $48,522,376 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
60,382 | $46,653,548 | |
| 3 | RPRX |
Royalty Pharma plc
|
544,033 | $26,097,263 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
54,269 | $17,955,984 | |
| 5 | INSM |
INSMED Inc
|
89,647 | $14,659,077 | |
| 6 | INCY |
Incyte Corp
|
136,241 | $12,823,002 | |
| 7 | EXEL |
Exelixis, Inc.
This page
|
276,296 | $11,850,335 | |
| 8 | MRNA |
Moderna, Inc.
|
153,407 | $7,793,075 |
All Filings in EXEL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,850,335 | 276,296 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $11,307,044 | 257,975 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $12,951,308 | 313,591 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $10,511,316 | 238,460 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,200,529 | 167,945 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,046,548 | 151,548 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,151,948 | 159,998 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,600,031 | 160,215 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,745,780 | 157,850 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,453,360 | 143,950 | Shares | Sole | 2024-05-09 | |
| 2023-09-30 | $3,175,744 | 145,343 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,763,401 | 144,605 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,714,003 | 139,825 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $2,199,966 | 137,155 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $2,123,150 | 135,405 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $2,935,869 | 141,012 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $2,585,037 | 114,029 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $2,051,454 | 112,224 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,356,771 | 111,484 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $1,962,749 | 107,725 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,546,683 | 112,735 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $2,268,211 | 113,015 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $3,463,220 | 141,645 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $3,472,331 | 146,265 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $2,122,537 | 123,260 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||